References
- LiptonRBDiamondSReedMDiamondMLStewartWFMigraine diagnosis and treatment: results from the American Migraine Study IIHeadache20014163864511554951
- BelvísRPagonabarragaJKulisevskyJIndividual triptan selection in migraine attack therapyRecent Pat CNS Drug Discov200941708119149716
- CadyRKSchreiberCPFarmerKUUnderstanding the patient with migraine: the evolution from episodic headache to chronic neurologic disease. A proposed classification of patients with headacheHeadache20044442643515147250
- VianaMSancesGGhiottoNVariability of the characteristics of a migraine attack within patientsCephalalgia Epub20151023
- CadyRFarmerKDexterJKSchreiberCCosensitization of pain and psychiatric comorbidity in chronic daily headacheCurr Pain Headache Rep200591475215625025
- YunusMBCentral sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illnessSemin Arthritis Rheum200837633935218191990
- DiamondSCadyRKDiamondMLGreenMWMartinVTHeadache and Migraine Biology and ManagementWaltham, MAAcademic Press2015
- CadyRKSchreiberCPSinus headache or migraine? Considerations in making a differential diagnosisNeurology2002589 Suppl 6S10S1412011268
- KanieckiRGMigraine and tension-type headache: an assessment of challenges in diagnosisNeurology2002589 Suppl 6S15S2012011269
- CadyRKLiptonRBRothrockJFChronic Migraine: A Patient-Centered Guide to Effective ManagementHamilton, ON, CanadaBaxter Publishing Inc2013
- LiptonRBBigalMEMigraine: Epidemiology, impact, and risk factors for progressionHeadache200545Suppl 1S3S1315833088
- AshinaSLiptonRBBigalMETreatment of comorbidities of chronic daily headacheCurr Treat Options Neurol2008101364318325298
- BuseDCManackASerranoDTurkelCLiptonRBSociodemographic and co morbidity profiles of chronic migraine and episodic migraine sufferersJ Neurol Neurosurg Psychiatry201081442843220164501
- ScherAIStewartWFLiptonRBThe comorbidity of headache with other pain syndromesHeadache20064691416142317040338
- NegroAD’AlonzoLMartellettiPChronic migraine: comorbidities, risk factors, and rehabilitationIntern Emerg Med20105Suppl 1S13S1920865469
- SinghGRecent considerations in nonsteroidal anti-inflammatory drug gastropathyAm J Med19981051B31S38S9715832
- WolfeMMLichtensteinDRSinghGGastrointestinal toxicity of nonsteroidal anti-inflammatory drugsN Engl J Med1999340241888189910369853
- SheftellFTepperSJNew paradigms in the recognition and acute treatment of migraineHeadache200242586912005277
- LucianiRCarterDMannixLHemphillMDiamondMCadyRKPrevention of migraine during prodrome with naratriptanCephalalgia20002012212610961768
- CadyRDodickDWDiagnosis and treatment of migraineMayo Clin Proc20027725526111888029
- KelmanLThe triggers or precipitants of the acute migraine attackCephalalgia200727539440217403039
- MartinVTBehbehaniMMToward a rational understanding of migraine trigger factorsMed Clin North Am20018591194111480265
- BuseDCAndrasikFBehavioral medicine for migraineNeurol Clin200927244546519289225
- Headache Classification Committee of the International Headache Society (IHS)The International Classification of Headache Disorders, 3rd edition (beta version)Cephalalgia201333609808
- CadyRKSheftellFLiptonRBEarly treatment with sumatriptan enhances pain-free responses: retrospective analysis from three clinical trialsClin Ther20002291035104811048903
- CarpayJSchoenenJAhmadFKinradeFBoswellDEfficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled studyClin Ther20042621422315038944
- MathewNTFinlaysonGSmithTREarly intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study)Headache20074718919817300358
- FoleyKACadyRKMartinVTreating early versus treating mild: timing of migraine prescription medications among patients with diagnosed migraineHeadache20054553855415953272
- LiptonRBFanningKMSerranoDReedMLCadyRBuseDCIneffective acute treatment of episodic migraine is associated with new-onset chronic migraineNeurology201584768869525609757
- SilbersteinSDPharmacological profile and clinical characteristics of frovatriptan in the acute treatment of migraine: introductionHeadache200242Suppl 2S42S46
- BuchanPKeywoodCWadeAWardCClinical pharmacokinetics of frovatriptanHeadache200242Suppl 2S54S6212028321
- GeraudGKeywoodCSenardJMMigraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptansHeadache20034337638812656709
- RyanRGeraudGGoldstwinJCadyRKeywoodCClinical efficacy of frovatriptan: placebo-controlled studiesHeadache200242Suppl 2S84S9212028324
- SaviLMogaveroSEganCGEfficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraineDrug Des Devel Ther20148983992
- SanfordMFrovatriptan: a review of its use in the acute treatment of migraineCNS Drugs201226979181122900951
- SpieringsELKeywoodCRapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label studyPain Med200910463363819453958
- CadyRSchreiberCFrovatriptan: clinical review and future directionsFuture Neurol2006111319
- RapoportARyanRGoldsteinJKeywoodCDose range-finding studies with frovatriptan in the acute treatment of migraineHeadache200242Suppl 2S74S8312028323
- ParsonsAARavalPSmithSEffects of novel high-affinity 5-HT-1B/1D receptor ligand frovatriptan in human isolated basilar and coronary arteriesJ Cardiovasc Pharmacol1998322202249700983
- ParsonsAAValocikRKosterPEffects of the novel anti-migraine agent frovatriptan on coronary and cardiac function in dogsJ Cardiovasc Pharmacol1997301361419268233
- GoldsteinJKeywoodCA lose dose finding study of frovatriptan (VML251) a potent cerebroselective 5-HT-1B/1D agonist for the acute treatment of migraine (abstract)Funct Neurol199813178
- GeraudGSpieringsELHKeywoodCTolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptanHeadache200242Suppl 2S93S9912028325
- CadyRKKeywoodCFrovatriptan: preliminary efficacy in the early treatment of migraine attacksCephalalgia200121426 Abstract #P2-K48
- CadyRElkindAGoldsteinJKeywoodCRandomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severeCurr Med Res Opin2004201465147215383196
- TulloVValguarneraFBarbantiPComparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized studyCephalalgia201434643444524363238
- NewmanLCLiptonRBLayCLSolomonSA pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraineNeurology1998513073099674831
- NewmanLCMannixLKLandySNaratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled studyHeadache20014124825611264684
- SilbersteinSDElkindAHSchreiberCPKeywoodCA random-ized trial of frovatriptan for the intermittent prevention of menstrual migraineNeurology20046326126915277618
- BrandesJLPooleAKallelaMShort-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacksCephalalgia200929111133114819811503
- CadyRKVoirinJFarmerKBrowningRBeachMETarraschJTwo center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implicationsHeadache201252574976422188311
- LisottoCLidia SaviLPinessiLEfficacy of frovatriptan vs other triptans in weekend migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studiesBrain Disord Ther201433128
- SaraccoMGAllaisGTulloVEfficacy of frovatriptan and other triptans in the treatment of acute migraine of normal weight and obese subjects: a review of randomized studiesNeurol Sci201435Suppl 111511924867847
- TulloVBussoneGOmboniSEfficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studiesNeurol Sci201334Suppl 1S87S9123695053